A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma

• Status: Completed
• Trial end date: 2006-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the safety and effectiveness of tacrolimus inhalation aerosol in subjects with persistent asthma.

• Phase: Phase 2

Details

• Lead Sponsor: Astellas Pharma Inc
• Collaborator: Astellas Pharma US, Inc.
• Treatments: Tacrolimus

Criteria

Inclusion Criteria:

• Diagnosis of persistent asthma for at least 6 months

• Require use of beta-agonists at least four times per week

Exclusion Criteria:

• Diagnosis of chronic obstructive pulmonary disease (COPD)